Meenakshi Ammal Dental College, Chennai, India.
RYA COSMO Foundation Hospital, Chennai, India.
Oral Maxillofac Surg. 2022 Mar;26(1):155-159. doi: 10.1007/s10006-021-00978-4. Epub 2021 Jun 5.
To compare the efficacy of dexamethasone when administered preoperatively through sublingual and intramuscular routes for evaluating the reduction in pain, swelling, and trismus after removal of impacted mandibular third molar.
The study was conducted on patients who required surgical removal of impacted mandibular third molars under local anesthesia. A total of 150 patients were considered for the study who were divided into two groups of 75 patients each. Patients in the sublingual group were administered with 2 ml of dexamethasone 8 mg along with 2 ml of normal saline through sublingual route and patients in the intramuscular group were administered with 2 ml of dexamethasone 8 mg through intramuscular route 1 h before the commencement of mandibular third molar surgery. The subjects of all two groups were evaluated for pain, swelling, and trismus on 1, 3, and 7 postoperative days.
Patients in the sublingual group had significantly less pain and increased mouth opening on 1, 3, and 7 postoperative days when compared to patients in the intramuscular group (P < 0.05), while the amount of swelling in the sublingual group was significantly less only on the 3 and 7 postoperative days when compared to patients in the intramuscular group (P < 0.05). Four patients in the sublingual group consumed one dose of paracetamol 500 mg as a rescue drug on the day of surgery. In the intramuscular group, 9 patients consumed one dose of the same rescue drug on the day of surgery and 11 patients consumed one dose of rescue drug both on the day of surgery and on the 1 postoperative day.
This study concludes that preoperative administration of dexamethasone 8 mg through sublingual route had better efficacy than intramuscular route in controlling pain, swelling and trismus after mandibular third molar surgery.
比较术前经舌下和肌肉途径给予地塞米松治疗下颌阻生第三磨牙拔除后疼痛、肿胀和牙关紧闭减轻的疗效。
本研究纳入需在局部麻醉下接受下颌阻生第三磨牙拔除术的患者。共纳入 150 例患者,分为舌下组和肌肉组,每组 75 例。舌下组患者舌下给予 2ml 地塞米松 8mg 加 2ml 生理盐水,肌肉组患者肌肉给予 2ml 地塞米松 8mg,在下颌第三磨牙手术开始前 1 小时给药。所有两组患者均在术后第 1、3 和 7 天评估疼痛、肿胀和牙关紧闭情况。
与肌肉组相比,舌下组患者术后第 1、3 和 7 天疼痛明显减轻,张口度增大(P<0.05),而舌下组患者肿胀程度仅在术后第 3 和 7 天明显减轻(P<0.05)。舌下组 4 例患者在手术当天服用了 1 片 500mg 扑热息痛作为解救药物。肌肉组中,9 例患者在手术当天服用了 1 片相同的解救药物,11 例患者在手术当天和术后第 1 天各服用了 1 片。
本研究表明,术前舌下给予 8mg 地塞米松在控制下颌第三磨牙手术后疼痛、肿胀和牙关紧闭方面比肌肉途径更有效。